Tailai An
Papers
1
Total Citations
19
H-Index
1
About
Dr. Tailai An is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer treatment. His work centers on comparing robotic and laparoscopic approaches to major hepatectomy, particularly for hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide. Dr. An’s most cited study, “Robotic versus laparoscopic major hepatectomy for hepatocellular carcinoma: short-term outcomes from a single institution” (2022, 19 citations), provides critical insights into the safety and efficacy of robotic surgery. This research demonstrates that robotic major hepatectomy offers comparable short-term outcomes to laparoscopic procedures, with potential advantages in precision and recovery. By systematically evaluating perioperative metrics such as operative time, blood loss, and complication rates, Dr. An has helped establish evidence-based guidelines for surgical decision-making in HCC management. His contributions are particularly impactful for surgeons seeking to optimize patient outcomes through technological innovation. With a growing citation record, Dr. An’s work continues to shape the evolving landscape of minimally invasive liver surgery, offering hope for improved prognoses in HCC patients.
Research Focus
Key Achievements
Top Papers
- 1